Objective: Ischemia followed by reperfusion in the presence of polymorphonuclear leukocytes (PMNs) results in cardiac contractile dysfunction as well as myocardial injury. These deleterious effects are due in large part to endothelial dysfunction leading to an upregulation of cell adhesion molecules and subsequent neutrophil-induced cardiac injury. At physiologically relevant concentrations, N,N,N-trimethylsphingosine (TMS), a synthetic N-methylated sphingosine derivative, has been shown to attenuate leukocyte-endothelial cell interactions. We wanted to test the effects of TMS on neutrophil-mediated cardiac dysfunction in ischemia / reperfusion. Methods: This study examines the effects of TMS in a neutrophil-dependent isolated perfused rat heart model of ischemia (I) (20 min) and reperfusion (R) (45 min) injury. Results: Administration of TMS (20 mg / kg) to I / R hearts perfused with PMNs improved coronary flow and preserved left ventricular developed pressure as an index of cardiac contractile function (9565%) in comparison to those I / R hearts receiving only vehicle (6067%) (P,0.001). In addition, TMS significantly reduced PMN accumulation in the ischemic myocardium, as evidenced by an attenuation in cardiac myeloperoxidase activity from 1.1260.04 in untreated hearts to 0.0160.02 in treated hearts (P,0.001). However, TMS did not directly stimulate nitric oxide (NO) release from rat vascular endothelium. Conclusion: These results provide evidence that TMS is a potent and effective cardioprotective agent that inhibits leukocyte-endothelial cell interactions and preserves cardiac contractile function and coronary perfusion following myocardial ischemia and reperfusion.
Introduction
tissue injury by the release of a variety of cytotoxic substances, including oxygen-derived free radicals, inflamEarly reperfusion of the ischemic myocardium plays an matory cytokines and proteolytic enzymes [6] . Many of important role in minimizing myocardial tissue injury these substances may mediate vascular endothelial associated with acute myocardial infarction. However, dysfunction as well as contribute to myocardial injury [7] . reperfusion of the myocardium itself results in enhanced This is also consistent with evidence that either decreasing myocardial injury [1, 2] . The process of reperfusion injury the number of circulating PMNs or the administration of is characterized by an inflammatory response in which monoclonal antibodies directed against cell adhesion molepolymorphonuclear leukocytes (PMNs) are believed to cules can lead to significant cardioprotection against play an important role [2, 3] . Upon reperfusion, many reperfusion injury [8] [9] [10] [11] . activated PMNs accumulate in the microvasculature, reSphingoglycolipids are known to play a physiological sulting in microvascular plugging and an impairment in role in the function of membrane ion transporters and exert coronary perfusion [4, 5] . The activated PMNs induce key effects on cell signal transduction pathways [12] . Recently, it has become evident that the biological activity of these compounds also applies to some of their deriva-not only sphingosine but a synthetic N-methylated ana-USA). All of the data were stored and analyzed at the end logue, N,N,N-trimethylsphingosine (TMS), demonstrates of each experiment. an inhibitory effect on protein kinase C (PKC) activity [13, 14] . TMS also reduces transendothelial migration of 2.2. Rat neutrophil isolation neutrophils and attenuates platelet aggregation at physiologic concentrations [15, 16] . It has previously been shown Sprague-Dawley rats (300-350 g), which were used as that TMS attenuates myocardial necrosis and endothelial neutrophil donors, received a 10-ml injection of 0.5% dysfunction in feline myocardial ischemia / reperfusion oyster glycogen i.p. (Sigma, St. Louis, MO, USA). Eigh-(MI / R) [17] . Therefore, TMS is considered to be a teen hours later, the rats were anesthetized using ethyl potentially effective agent in attenuating myocardial reether and the neutrophils were harvested by peritoneal perfusion injury. The major purpose of this study was to lavage in 20 ml of phosphate-buffered saline (PBS). The investigate if the administration of TMS is able to protect peritoneal lavage was centrifuged at 20003g at 48C for 10 against cardiac contractile dysfunction and PMN accumumin and washed twice, as described previously [19] . lation associated with ischemia reperfusion injury in a Finally, the PMNs were resuspended in Krebs buffer and carefully controlled model of rat MI / R, which is depencounted using a hemocytometer and microscope. These dent upon neutrophils to mediate the cardiac contractile neutrophil preparations were .95% pure, and .95% dysfunction. A second purpose of this study was to viable using 0.3% trypan blue exclusion as the criterion for investigate the interaction between TMS and endothelial viability. Furthermore, PMNs obtained by this method nitric oxide (NO).
have been found to respond normally in cell adhesion tests [19] . Additional PMNs were isolated from rat blood by the method of Williams et al.
[20] using the hetastarch 2. Methods exchange transfusion method in pentobarbital-anesthetized 6 (40 mg / kg, i.p.) rats. This method yielded 110-130310 All experiments reported in this study conform to PMNs per rat, which were .95% pure and .95% viable. Thomas Jefferson University IACUC guidelines regarding These PMNs were washed five to six times to remove the the use of animals in the laboratory as well as the standard hetastarch prior to perfusion into rat hearts. in the Guide for the Care and Use of Laboratory Animals (NIH Publication Number 85-23, revised 1985).
2.3. Rat plasma preparation
Isolated rat heart experiments
An intracardiac puncture was performed in anesthetized rats with a 20-ml plastic syringe and a 20 gauge needle Male Sprague-Dawley rats (250-300 g) were anes-(Becton Dickinson, Franklin Lakes, NJ, USA) containing thetized with 40 mg / kg sodium pentobarbital and 1000 U 2.0 ml of sodium citrate-phosphate-dextrose solution, to of sodium heparin were administered i.p. (Elkins Sinn, obtain whole blood. The blood was centrifuged immediCherry Hill, NJ, USA). Following a midline thoracotomy, ately in a refrigerated centrifuge (GSGR; Beckman Instruthe hearts were rapidly excised, the ascending aorta was ments, Palo Alto, CA, USA) at 20003g for 10 min, and cannulated, and retrograde perfusion of the non-working the plasma was decanted. The plasma was infused along heart was initiated with a modified Krebs buffer mainwith the PMNs in order to more closely simulate the tained at 378C and at a constant pressure of 80 mmHg. The conditions present in vivo. Krebs buffer had the following composition (in mmol / l): glucose, 17; NaCl, 120; NaHCO , 25; CaCl , 2.5; EDTA, 2.4. Perfused heart experimental protocol 3 2 0.5; KCl, 5.9 and MgCl , 1.2. The perfusate was aerated 2 with 95% O 15% CO , which was equilibrated at a pH of After the first 15 min of perfusion, baseline left ventricu- 2 2 7.3 to 7.4. Two sidearms of the apparatus in the perfusion lar developed pressure (LVDP), 1dP/ dt max and coronary line just proximal to the heart inflow cannula allowed the flow were measured every 5 min for 15 min, to ensure infusion of PMNs and plasma, with or without TMS, complete equilibration of the hearts. LVDP was defined as directly into the coronary inflow line. To assess cardiac left ventricular systolic minus left ventricular end-diastolic contractile function, a 2.5 Fr microtip catheter transducer pressure. In all of the hearts, at both the initial and final (Millar Instruments, Houston, TX, USA) was inserted reading, end-diastolic pressure was 4 to 8 mmHg. The first directly into the left ventricular cavity, as previously derivative of left ventricular pressure (1dP/ dt max) was reported [18, 19] . The left ventricular pressure, the maximal recorded from instantaneous left ventricular pressure. Flow rate of development of left ventricular developed pressure of the Krebs buffer was then reduced to zero, creating a (1dP/ dt max) and coronary flow were all recorded using a state of total global ischemia. This ischemia was mainMacLab data acquisition system (ADI Diagnostics, Castle tained for 20 min. The flow was then allowed to return to Hill, NSW, Australia) in conjunction with a Power Macinvalues near control levels by re-establishing coronary and 5 ml of plasma were infused directly into the coronary electrode (World Precision Instruments, Orlando, FL, circulation over a period of 5 min via a set of side ports USA) according to the method of Weyrich et al. [24] . The situated just proximally to the heart in the perfusion line.
fluid surrounding these aortic segments with intact endoThe PMNs were suspended in 5.0 ml of Krebs buffer in a thelium were tested for NO release in the presence and 5.0-ml syringe. The plasma was also placed in a 5.0 ml absence of TMS. syringe located just proximal to the inflow port to the coronary circulation. The hearts were allowed to reperfuse 2.7. Statistical analysis for a total of 45 min, during which time the data were collected every 5 min for the first 30 min and at the 45 min All data in the text and figures are presented as the time point. TMS was diluted in Krebs buffer according to mean6S.E.M. The data on left ventricular function and previously described methods [21] . We determined that coronary flow were analyzed by ANOVA, incorporating 20.0 mg / kg body weight of this agent was an effective repeated measures. The MPO data were compared with an cardioprotective dose, and this dose was infused with the ANOVA using post-hoc analysis with Fisher's corrected plasma over the first 5 min of reperfusion. Preliminary t-test. Probability values of 0.05 or less were considered to studies using 0.2 mg / kg of TMS were without any be statistically significant. cardioprotective effect, and 2 mg / kg were only moderately protective. measured, indicating that PMNs do not induce cardiac dysfunction in normal non-ischemic hearts. Only in is-2.6. Isolated rat aortic rings chemic reperfused rat hearts perfused with PMNs was there a marked reduction in cardiac contractile function Rat aortae were isolated from pentobarbital-anesthetized and coronary flow. Only a slight degree of protection was (pentobarbital sodium, 40 mg / kg, i.p.) rats and carefully observed when TMS was infused 20 min after reperfusion dissected into rings that were 2 to 3 mm in length, with PMNs. Final LVDP decreased to 5363% of the initial preserving the integrity of the endothelium. The rings were value in untreated ischemic-reperfused hearts and to suspended in oxygenated 10 ml organ baths and subjected 64610% of control in ischemic-reperfused rat hearts to a 1.0-g resting force, as described previously [24] . TMS treated with 20 mg / kg TMS starting 20 min following (0.6 mg / ml) was added to the bath alone and prior to the reperfusion. These values are not significantly different. addition of 100 nM acetylcholine or 100 mM acidified Ischemic-reperfused hearts perfused with PMNs and NaNO (pH 2.0). NaNO at pH 7.4 exerted no vasoactive plasma exhibited significant cardiac dysfunction in these 2 2 effects. Aortic rings were precontracted with 10 nM hearts (P,0.01). In a direct comparison with PMNs U46619 (Biomol Laboratories, Plymouth Meeting, PA, isolated from the peritoneal fluid and PMNs isolated from USA; 9,11-methano-epoxy PGH ). Additional aortic rings, blood, the degree of cardiac dysfunction was very similar. 2 flattened out in cell culture dishes, were placed in contact Fig. 1 illustrates the initial and final LVDPs of rat hearts with a calibrated self-grounded selective nitric oxide subjected to ischemia-reperfusion and perfused with either peritoneal PMNs or blood PMNs. These results indicate or in I / R hearts without the addition of PMNs, there are that the source of PMNs is not a significant factor in this very few resident PMNs. However, I / R hearts perfused in model of myocardial ischemia-reperfusion. Coronary flow, the presence of PMNs showed a highly significant MPO maintained at zero during ischemia, showed a recovery of activity, signifying PMN accumulation (P,0.001). Fur-8062% of control in the presence of PMNs (Fig. 2) . thermore, when these ischemic / reperfused hearts were However, with the same number of PMNs under the same perfused with PMNs and given TMS after reperfusion, conditions in the presence of TMS, coronary flow rethere was a significant attenuation of the MPO activity covered almost completely (Fig. 2) .
(P,0.001; Fig. 5 ), indicating an anti-neutrophil effect of Changes in left ventricular function (i.e., LVDP) were TMS. These effects on MPO activity are reflective of PMN similar to those of coronary flow. In ischemic reperfused infiltration, since the direct addition of 0.6 mg/ml TMS to rat hearts perfused with PMNs, LVDP recovered only PMN pellets did not significantly alter MPO activity. In partially following reperfusion stabilizing at a deficit in four such pairs of experiments, TMS-treated PMN pellets LVDP of 5065% (P,0.001) (Fig. 3) . However, in hearts exhibited an MPO activity of 0.1760.03 U / g vs. perfused with the same number of PMNs under the same 0.1160.03 for the Krebs buffer-treated PMN pellets. These I / R conditions, TMS showed a significant protective effect values are not significantly different. Moreover, in three in LVDP, to 9663% of initial values.
ischemic-reperfused hearts given vehicle, there were These same relationships were obtained with the first 13.061.2 PMNs / field compared with 1.160.3 PMNs / field derivative of LVDP (1dP/ dt max). There was a 5564% in ischemic reperfused rat hearts given 20 mg/kg TMS reduction in the final 1dP/ dt max in untreated PMN (P,0.001), thus confirming the MPO data. perfused hearts subjected to ischemia / reperfusion (P, In eight isolated rat aortic rings, TMS at 0.6 mg / ml 0.001; Fig. 4) . However, ischemic / reperfused hearts given exerted no direct vasoactive effects; 161% relaxation in TMS showed a significantly marked recovery of cardiac eight aortic rings. Moreover, incubation of eight rat aortic contractility, comparable to that of control values (i.e., rings with 0.6 mg / ml TMS for 45 min did not significantly 9862% of control).
alter the vasorelaxation response to either acetylcholine In all of the control hearts and non-PMN-perfused (9462 vs. 9062%, TMS vs. its vehicle, i.e., Krebs buffer) ischemia / reperfusion hearts, no cardiac MPO activity or NaNO . For NaNO , the comparable percentage relaxa- 2 2 could be detected, indicating that, in non-ischemic hearts tion responses were 9961 vs. 10061. Neither of these comparisons are significantly different from each other, a series of sequential processes that are mediated by and suggest that TMS does not release physiologically different cell adhesion molecules located either on the meaningful amounts of NO from the vascular endothelium.
PMNs or the endothelial cells [28] . Upon reperfusion, an To ascertain if TMS could directly release NO, we tested increased number of PMNs start to roll along the endo-TMS in aortic segments with a NO electrode. Basal NO thelial surface, a process mainly mediated by P-selectin release was 1862 vs. 2062 pmol NO / mg tissue in the upregulation on the endothelium and to a lesser extent by presence of 0.6 mg / ml TMS in five isolated rat aortic constitutively expressed L-selectin on the PMNs [28, 29] . segments. In the presence of 100 mM L-arginine, to
Rolling PMNs are then able to engage in firm adhesion to stimulate NO production, these values were 4165 vs. the endothelium, mainly by b integrin (i.e., CD11 / CD18) 2 4564 pmol NO released / mg tissue. Neither of these interaction with intercellular adhesion molecule-1 (ICAMcomparisons were statistically significant. 1), which is located on the endothelium [28] . After firm adhesion, many of the PMNs then become activated, flatten out and undergo transendothelial migration to the 4. Discussion injured or inflamed tissue [30] . It is known that the respiratory burst of PMNs (i.e., the production of oxygenThis study clearly demonstrates a significant cardioderived free radicals) at the onset of reperfusion coincides protective action of low concentrations of TMS in a with a marked reduction in nitric oxide release from the Langendorff perfused heart model of myocardial ischemia / endothelium [31] , which may in turn lead to an enhanced reperfusion. This cardioprotection was characterized by expression of P-selectin on the endothelial surface [32-significant maintenance of post-reperfusion coronary flow, 34]. In recent studies, in vivo administration of monoclonal left ventricular developed pressure and the first derivative antibodies against various cell adhesion molecules was of left ventricular developed pressure (i.e., dP/ dt max)
shown to significantly attenuate PMN adherence to the indicating a significant attenuation of cardiac dysfunction endothelium and to curtail myocardial necrosis after MI / R by this phospholipid. It is unlikely that TMS exerted its [8, 10] . In this regard, TMS has been shown to attenuate cardioprotective effects by directly influencing hemodysurface expression of P-selectin on coronary endothelial namics (i.e., inducing coronary vasodilation or increased cells during reperfusion of the ischemic heart [21]. cardiac contractility) since TMS does not affect hemoIn the present study, TMS protected cardiac function dynamic parameters when administered in vivo [17] . This after ischemia and reperfusion. It is known that endothelial concept is also consistent with the data obtained in the dysfunction occurs within 2.5 to 5 min of the onset of present study, showing that there were no increases in reperfusion and is characterized by a reduction in the coronary flow or left ventricular developed pressure in the release of biologically active NO [2] . However, TMS did non-ischemic hearts infused with TMS.
not directly promote the release of NO by the vascular Since myocardial reperfusion injury has been shown to endothelium, suggesting that TMS protects by preserving be related to PMNs infiltrating into ischemic cardiac tissue endothelial function rather than by directly stimulating the [2, 10, 25] , one very important component of the protection release of additional NO from the endothelium. Studies afforded by TMS is due to its inhibition of PMN accumuhave shown that the loss of endothelium-derived NO lation in the ischemic myocardium. Approximately 90% further facilitates PMN adherence to the vascular endoattenuation of cardiac MPO activity was observed in TMSthelium [35, 36] . These adherent PMNs are activated and treated ischemic-reperfused hearts compared to those I / R release mediators that aggravate endothelial dysfunction, hearts given only the vehicle. This attenuation of resulting in an increased PMN adherence to the vascular leukocyte-endothelium interaction appears to be the key endothelium and myocardial necrosis [36] . Because NO cardioprotective effect of TMS. Consistent with this coninhibits PMN adherence to the endothelium, the dimincept, Murohara et al. [17] demonstrated that TMS exished PMN adherence to the coronary endothelium after hibited a 50% protection in PMN adherence to thrombinreperfusion may be explained, at least in part, by preservastimulated coronary endothelium. Without TMS, neutrotion of the endothelial NO production by TMS, eventually phils adhere to the endothelium of the vasculature and preventing myocardial necrosis and cardiac dysfunction release cytotoxic substances, such as proteases, [35] . eicosanoids, cytokines and oxygen-derived free radicals
In conclusion, we have demonstrated that low doses of a [6] , each of which can mediate tissue injury and exacerbate sphingolipid membrane derivative, TMS, can attenuate endothelial dysfunction. These humoral mediators have cardiac contractile dysfunction related to myocardial isbeen found to lead to coronary endothelial injury, disrupchemia-reperfusion injury in vitro, by interfering with tion of the endothelial basement membranes, PMN exneutrophil-endothelial cell interactions. This study protravasation and myocardial necrosis [5, 6, 26, 27] . Our findvides strong evidence that TMS, an N-methylated derivaing of reduced MPO accumulation supports the concept tive of a sphingolipid, has important beneficial effects on that TMS attenuates PMN-endothelial cell interactions.
acute inflammatory tissue injury, such as that occurring in Recruitment of PMNs to inflammatory tissue consists of the reperfusion of the ischemic myocardium. These studies 
